 | Homidium bromide | IC50 | 2500.0 [1] |
 | (E)-2-(3-(Naphthalen-2-yl)but-2-enamido)benzoic acid | IC50 | 280.0 [1] |
 | Telomestatin | IC50 | 20.0 [1] |
 | 7,8,3',4'-Tetrahydroxyflavone | IC50 | 230.0 [1] |
 | Braco-19 | IC50 | 90.0 [1] |
 | Telomerase Inhibitor IX | IC50 | 670.0 [1], 12100.0 [2], 12800.0 [3] |
 | beta-Rubromycin | IC50 | 1320.0 [1], 1530.0 [2], 3000.0 [3], 3060.0 [4] |
 | CID 11430774 | IC50 | 45.0 [1], 52.0 [2], 63.0 [3], 5600.0 [4], 8400.0 [5] |
 | Phen-DC3 | IC50 | 1.5 [1], 2.2 [2], 63.0 [3], 790.0 [4], 1500.0 [5] |
 | Staurosporine | IC50 | 4140.0 [1], 8300.0 [2], 8320.0 [3], 8970.0 [4] |
 | (-)-Epigallocatechin gallate | IC50 | 1000.0 [1], 1080.0 [2], 1180.0 [3] |
 | Acridine orange | IC50 | 12200.0 [1] |
 | Ethacridine | IC50 | 8200.0 [1] |
 | Acridine Yellow | IC50 | 21700.0 [1] |
 | (3R,4S,7R,10R)-3-[(1S,2S,4Ar,8aS)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-10-hydroxy-5-oxa-1-azatricyclo[5.2.1.04,10]decane-2,6-dione | IC50 | 1300.0 [1] |
 | Meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) | IC50 | 550.0 [1], 710.0 [2], 740.0 [3] |
 | N-[9,10-Dioxo-6-(3-pyrrolidin-1-ylpropanoylamino)anthracen-2-yl]-3-pyrrolidin-1-ylpropanamide | IC50 | 1800.0 [1] |
 | 3-Pyrrolidin-1-YL-N-[6-(3-pyrrolidin-1-YL-propionylamino)-acridin-3-YL]-propionamide | IC50 | 5200.0 [1] |
 | 3,6-Bis[3-(Azepan-1-Yl)propionamido]acridine | IC50 | 3100.0 [1] |
 | 3,6-Bis[3-(heptamethyleneimino)piperizinopropionamido)acridine | IC50 | 50000.0 [1] |
 | 3,6-Bis(3-piperidinopropionamido)acridine | IC50 | 2800.0 [1] |
 | 2,7-Bis[3-(piperidino)propionamido]anthraquinone | IC50 | 3100.0 [1], 8400.0 [2] |
 | 2-(2,6-Dichloro-benzylsulfanyl)-6-formyl-nicotinonitrile | IC50 | 7000.0 [1], 77000.0 [2], 113280.0 [3] |
 | Tanshinone IIA | IC50 | 500.0 [1], 5000.0 [2] |
 | Tmpyp | IC50 | 60.0 [1], 147.0 [2] |
 | Isometamidium | IC50 | 100.0 [1], 19054607.18 [2] |
 | 9,10-Phenanthrenequinone | IC50 | 500.0 [1], 5000.0 [2] |
 | 7,8-Dihydroxyflavone | IC50 | 36000.0 [1] |
 | Helenalin | IC50 | 4000.0 [1] |
 | Cryptolepine | IC50 | 9400.0 [1] |
 | 7,3',4'-Trihydroxyflavone | IC50 | 40000.0 [1] |
 | Syuiq-5 | IC50 | 440.0 [1], 630.0 [2] |
 | 7,8,4'-Trihydroxyflavone | IC50 | 3000.0 [1] |
 | 2,6-Bis[3-(1-piperidinyl)propanoylamino]anthraquinone | IC50 | 4500.0 [1] |
 | 2,7-Bis[3-(Diethylamino)Propionamido]Anthraquinone | IC50 | 4300.0 [1] |
 | Chrolactomycin | IC50 | 500.0 [1] |
 | 2,7-Bis[3-(Dimethylamino)Propionamido]Anthraquinone | IC50 | 4700.0 [1] |
 | 2,7-Bis[3-(pyrrolidino)propionamido]anthraquinone | IC50 | 2000.0 [1], 6700.0 [2] |
 | N-[9-(4-Aminoanilino)-6-(3-pyrrolidin-1-ylpropanoylamino)acridin-3-yl]-3-pyrrolidin-1-ylpropanamide | IC50 | 60.0 [1], 74.0 [2] |
 | N-[9-[2-(1-Methylpyrrolidin-2-yl)ethylamino]-6-(3-pyrrolidin-1-ylpropanoylamino)acridin-3-yl]-3-pyrrolidin-1-ylpropanamide | IC50 | 18.0 [1] |
 | N',N'-Dimethyl-N-(16-nitro-4,12-diazapentacyclo[11.8.0.02,11.05,10.014,19]henicosa-1(13),2(11),3,5,7,9,14(19),15,17,20-decaen-3-yl)propane-1,3-diamine | IC50 | 500.0 [1] |
 | 3-Morpholin-4-yl-N-[7-(3-morpholin-4-ylpropanoylamino)-9,10-dioxoanthracen-2-yl]propanamide | IC50 | 50000.0 [1] |
 | 3,6-Bis[(3-morpholinopropionamido)] acridine | IC50 | 50000.0 [1] |
 | 3,6-Bis[3-(4-methylpiperidino)propionamido]acridine | IC50 | 1350.0 [1] |
 | 3-(1,3,3-Trimethyl-6-azabicyclo[3.2.1]octan-6-yl)-N-[6-[3-(1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 50000.0 [1] |
 | 3-(4-Benzylpiperidin-1-yl)-N-[6-[3-(4-benzylpiperidin-1-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 50000.0 [1] |
 | 3-(2-Ethylpiperidin-1-yl)-N-[6-[3-(2-ethylpiperidin-1-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 2700.0 [1] |
 | 3-Diethylamino-N-[6-(3-diethylamino-propionylamino)-acridin-3-yl]-propionamide | IC50 | 5800.0 [1] |
 | 3-Dimethylamino-N-[6-(3-dimethylamino-propionylamino)-acridin-3-yl]-propionamide | IC50 | 8200.0 [1] |
 | 3-(3-Methylpiperidin-1-yl)-N-[6-[3-(3-methylpiperidin-1-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 4400.0 [1] |
 | 3-(2-Methylpiperidin-1-yl)-N-[6-[3-(2-methylpiperidin-1-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 2600.0 [1] |
 | 3-[2-(Hydroxymethyl)piperidin-1-yl]-N-[6-[3-[2-(hydroxymethyl)piperidin-1-yl]propanoylamino]acridin-3-yl]propanamide | IC50 | 5400.0 [1] |
 | 3-(4-Hydroxypiperidin-1-yl)-N-[6-[3-(4-hydroxypiperidin-1-yl)propanoylamino]acridin-3-yl]propanamide | IC50 | 8000.0 [1] |
 | 3-[2-(2-Hydroxyethyl)piperidin-1-yl]-N-[6-[3-[2-(2-hydroxyethyl)piperidin-1-yl]propanoylamino]acridin-3-yl]propanamide | IC50 | 4100.0 [1] |
 | 5-Morpholin-4-yl-2-[[(E)-3-naphthalen-2-ylbut-2-enoyl]amino]benzoic acid | IC50 | 470.0 [1] |
 | 4,11-Diaminonaphtho[2,3-f][1]benzothiole-5,10-dione | IC50 | 10000.0 [1], 33000.0 [2] |
 | 9,12,15,29,32,35,42,44-Octazaheptacyclo[35.3.1.13,7.14,40.117,21.120,24.123,27]hexatetraconta-1(40),2,4(42),5,7(46),17(45),18,20(44),21,23,25,27(43),37(41),38-tetradecaene | IC50 | 750.0 [1] |
 | 3-(4-Methylmorpholin-4-ium-4-yl)-N-[7-[3-(4-methylmorpholin-4-ium-4-yl)propanoylamino]-9,10-dioxoanthracen-2-yl]propanamide | IC50 | 16500.0 [1] |
 | [3-[[9,10-Dioxo-7-[3-(trimethylazaniumyl)propanoylamino]anthracen-2-yl]amino]-3-oxopropyl]-trimethylazanium | IC50 | 14500.0 [1] |
 | 3-(1-Methylpiperidin-1-ium-1-yl)-N-[7-[3-(1-methylpiperidin-1-ium-1-yl)propanoylamino]-9,10-dioxoanthracen-2-yl]propanamide | IC50 | 7800.0 [1] |
 | 2-(3,4-Dimethoxyphenyl)-7,8-dihydroxy-4H-chromen-4-one | IC50 | 11700.0 [1] |
 | 2-(3,4-Dihydroxyphenyl)-8-hydroxy-4H-chromen-4-one | IC50 | 40000.0 [1] |
 | 4,11-Bis[2-(methylamino)ethylamino]naphtho[2,3-f][1]benzothiole-5,10-dione;hydrochloride | IC50 | 500.0 [1], 700.0 [2] |
 | 2-[2-[[4-[2-(Diaminomethylideneamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-11-yl]amino]ethyl]guanidine;hydrochloride | IC50 | 80.0 [1], 700.0 [2] |
 | (3-Chlorophenyl) 12-[[2-[1-[3-(3-methylindol-1-yl)propyl]indol-3-yl]acetyl]amino]dodecyl hydrogen phosphate;N,N-diethylethanamine | IC50 | 3400.0 [1], 79000.0 [2] |
 | 6-Formylpyridine-2-carbothionic acid-S-3,4-dichlorophenyl ester | IC50 | 24000.0 [1], 33090.0 [2] |
 | 1,4-Bis[[3-(4-methylmorpholinium-4-yl)propionyl]amino]-9,10-anthraquinone | IC50 | 34500.0 [1] |
 | [3-[[9,10-Dioxo-6-[3-(trimethylazaniumyl)propanoylamino]anthracen-2-yl]amino]-3-oxopropyl]-trimethylazanium | IC50 | 17300.0 [1] |
 | [3-[[7-[3-[Diethyl(methyl)azaniumyl]propanoylamino]-9,10-dioxoanthracen-2-yl]amino]-3-oxopropyl]-diethyl-methylazanium | IC50 | 20000.0 [1] |
 | 2-[2-[(11-Amino-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl)amino]ethyl]guanidine | IC50 | 900.0 [1], 2000.0 [2] |
 | 2-[2-[(4-Amino-5,10-dioxonaphtho[2,3-f][1]benzothiol-11-yl)amino]ethyl]guanidine | IC50 | 500.0 [1], 3000.0 [2] |
 | 2-[2-[[11-[2-(Methylamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine | IC50 | 300.0 [1], 600.0 [2] |
 | 2-[2-[[4-[2-(Methylamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-11-yl]amino]ethyl]guanidine | IC50 | 50.0 [1], 1100.0 [2] |
 | 2-[2-[[11-(2-Aminoethylamino)-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine | IC50 | 100.0 [1], 800.0 [2] |
 | 2-[2-[[11-(3-Aminopropylamino)-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]guanidine | IC50 | 70.0 [1], 700.0 [2] |
 | N'-[2-[[11-[2-(1-Aminoethylideneamino)ethylamino]-5,10-dioxonaphtho[2,3-f][1]benzothiol-4-yl]amino]ethyl]ethanimidamide | IC50 | 300.0 [1], 470.0 [2] |
 | 1,4-Bis[[3-(1-methylpiperidinium-1-yl)propionyl]amino]-9,10-anthraquinone | IC50 | 11100.0 [1] |
 | 12-[[2-[1-[2-(5-Chloroindol-1-yl)ethyl]indol-3-yl]acetyl]amino]dodecyl cyclohexyl hydrogen phosphate | IC50 | 8700.0 [1], 101000.0 [2] |
 | 12-[[2-[1-[2-(5-Chloroindol-1-yl)ethyl]indol-3-yl]acetyl]amino]dodecyl (3-chlorophenyl) hydrogen phosphate | IC50 | 2500.0 [1], 70000.0 [2] |
 | 12-[[2-[1-[2-(5-Chloroindol-1-yl)ethyl]indol-3-yl]acetyl]amino]dodecyl phenyl hydrogen phosphate | IC50 | 6700.0 [1], 61000.0 [2] |
 | Doxorubicin | IC50 | 73000.0 [1] |
 | Camptothecin | IC50 | 300000.0 [1] |
 | Resveratrol | IC50 | 85000.0 [1] |
 | Oleic acid | IC50 | 8600.0 [1] |
 | Berberine | IC50 | 37000.0 [1] |
 | 1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | IC50 | 200.0 [1] |
 | Celastrol | IC50 | 780.0 [1] |
 | Allicin | IC50 | 500.0 [1] |
 | Costunolide | IC50 | 65000.0 [1] |
 | 2'-3'-Dideoxyguanosine-5'-triphosphate | IC50 | 8600.0 [1] |
 | Vaccenic acid | IC50 | 16000.0 [1] |
 | Unii-ST04094S3X | IC50 | 37300.0 [1] |
 | 3',4'-Dihydroxyflavone | IC50 | 40000.0 [1] |
 | Petroselinic acid | IC50 | 15000.0 [1] |
 | 3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-KL]acridin-13-ium | IC50 | 331131121.48 [1] |
 | Altertoxin I | IC50 | 1000000.0 [1] |
 | 7,8,3'-Trihydroxyflavone | IC50 | 50000.0 [1] |
 | Meridine | IC50 | 11000.0 [1] |
 | Okanin | IC50 | 6000.0 [1] |
 | Telomerase Inhibitor IV | IC50 | 200.0 [1] |